Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TEVA-AZITHROMYCIN DIN 02267845

Status: Marketed
Holder: TEVA CANADA LIMITED
Molecule: AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE)

Health Canada record

Active ingredient(s)AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ01FA10 AZITHROMYCIN
Original market date01-Dec-2005
Current status date03-Mar-2017
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE)

DINProductCompanyFormStrengthStatus
02363364AVA-AZITHROMYCINAVANSTRA INCTabletAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MGCancelled Post Market
02282429DOM-AZITHROMYCINDOMINION PHARMACALPowder For SuspensionAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 100 MGCancelled Pre Market
02282437DOM-AZITHROMYCINDOMINION PHARMACALPowder For SuspensionAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 200 MGCancelled Pre Market
02278502DOM-AZITHROMYCINDOMINION PHARMACALTabletAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 600 MGCancelled Post Market
02278499DOM-AZITHROMYCINDOMINION PHARMACALTabletAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MGCancelled Post Market
02278359MYLAN-AZITHROMYCINMYLAN PHARMACEUTICALS ULCTabletAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MGCancelled Post Market
02315157NOVO-AZITHROMYCIN PEDIATRICTEVA CANADA LIMITEDPowder For SuspensionAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 100 MGCancelled Post Market
02315165NOVO-AZITHROMYCIN PEDIATRICTEVA CANADA LIMITEDPowder For SuspensionAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 200 MGCancelled Post Market
02282380PHL-AZITHROMYCINPHARMEL INCPowder For SuspensionAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 100 MGCancelled Post Market
02278588PHL-AZITHROMYCINPHARMEL INCTabletAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MGCancelled Post Market
02278596PHL-AZITHROMYCINPHARMEL INCTabletAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 600 MGCancelled Pre Market
02282410PHL-AZITHROMYCINPHARMEL INCPowder For SuspensionAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 200 MGCancelled Post Market
02275287RATIO AZITHROMYCINRATIOPHARM INC DIVISION OF TEVA CANADA LIMITEDTabletAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MGCancelled Post Market
02270358SANDOZ AZITHROMYCINSANDOZ CANADA INCORPORATEDTabletAZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 500 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
325332024-01-17Supplement to an Abbreviated New Drug Submission (SANDS)Update to the Product Monograph. Product Monograph reformatted to the Master Template. Update to the Package Insert
153972014-03-07Abbreviated New Drug Submission (ANDS)MANUFACTURER NAME CHANGE
75922005-11-04Abbreviated New Drug Submission (ANDS)
Request a quote for TEVA-AZITHROMYCIN

How to read a Canadian DIN record